|
1）Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410: 701-5
|
|
|
|
2）Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763-76
|
|
|
|
|
3）Bolli R, Chugh AR, DAmario D, et al. Cardiac stem cells in patients with ischaemic cardiomyo-pathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011; 378: 1847-57
|
|
|
|
|
|
4）Zaruba MM, Soonpaa M, Reuter S, et al. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation. 2010; 121: 1992-2000
|
|
|
|
|
|
5）Fazel S, Cimini M, Chen L, et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006; 116: 1865-77
|
|
|
|
|
|
6）Cai CL, Liang X, Shi Y, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003; 5: 877-89
|
|
|
|
|
|
7）Martin-Puig S, Wang Z, Chien KR. Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell. 2008; 2: 320-31
|
|
|
|
|
|
8）Moretti A, Caron L, Nakano A, et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversifica-tion. Cell. 2006; 127: 1151-65
|
|
|
|
|
|
9）Bu L, Jiang X, Martin-Puig S, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature. 2009; 460: 113-7
|
|
|
|
|
|
10）Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003; 100: 12313-8
|
|
|
|
|
|
11）Wang X, Hu Q, Nakamura Y, et al. The role of the sca-1+/CD31- cardiac progenitor cell popu-lation in postinfarction left ventricular remodel-ing. Stem Cells. 2006; 24: 1779-88
|
|
|
|
|
|
12）Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hemato-poietic stem cells that are replicating in vivo. J Exp Med. 1996; 183: 1797-806
|
|
|
|
|
|
13）Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001; 107: 1395-402
|
|
|
|
|
|
14）Oyama T, Nagai T, Wada H, et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol. 2007; 176: 329-41
|
|
|
|
|
|
15）Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95: 911-21
|
|
|
|
|
|
16）Takehara N, Tsutsumi Y, Tateishi K, et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008; 52: 1858-65
|
|
|
|
|
|
17）Zhou B, Ma Q, Rajagopal S, et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature. 2008; 454: 109-13
|
|
|
|
|
|
18）Cai CL, Martin JC, Sun Y, et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature. 2008; 454: 104-8
|
|
|
|
|
|
19）Smart N, Bollini S, Dube KN, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011; 474: 640-4
|
|
|
|
|
|
20）Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7
|
|
|
|
|
|
21）Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012 Feb 15; 2: CD006536
|
|
|
|
|
|
22）Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011; 109: 923-40
|
|
|
|
|
|
23）Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005; 102: 11474-9
|
|
|
|
|
|
24）Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98: 1076-84
|
|
|
|
|
|
25）Okura H, Saga A, Soeda M, et al. Intracoronary artery transplantation of cardiomyoblast-like cells from human adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction and survival in a swine model of chronic myocardial infarction. Biochem Biophys Res Commun. 2012; 425: 859-65
|
|
|
|
|
|
26）Eisen HJ. Skeletal myoblast transplantation: No magic bullet for ischemic cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2008; 5: 520-1
|
|
|
|
|
|
27）Sawa Y, Miyagawa S, Sakaguchi T, et al. Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case. Surg Today. 2012; 42: 181-4
|
|
|
|
|
28）Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007; 25: 1015-24
|
|
|
|
|
|
29）Shiba Y, Fernandes S, Zhu WZ, et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature. 2012; 489: 322-5
|
|
|
|
|
|
30）Masumoto H, Matsuo T, Yamamizu K, et al. Pluripotent stem cell-engineered cell sheets re-assembled with defined cardiovascular popula-tions ameliorate reduction in infarct heart func-tion with cardiomyocyte-mediated neovasculariza-tion. Stem Cells. 2012; 30: 1196-205
|
|
|
|
|
|
31）Yamashita JK, Takano M, Hiraoka-Kanie M, et al. Prospective identification of cardiac progenitor potentials by a novel single cell-based cardio-myocyte induction. FASEB J. 2005; 19: 1534-6
|
|
|
|
|
|
32）Dubois NC, Craft AM, Sharma P, et al. SIRPA is a specific cell-surface marker for isolating cardio-myocytes derived from human pluripotent stem cells. Nat Biotechnol. 2011; 29: 1011-8
|
|
|
|
|
|
33）Pelacho B, Mazo M, Gavira JJ, et al. Adult stem cells: from new cell sources to changes in methodology. J Cardiovasc Transl Res. 2011; 4: 154-60
|
|
|
|
|
|
34）Teng CJ, Luo J, Chiu RC, Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg. 2006; 132: 628-32
|
|
|
|
|
|
35）Mirotsou M, Jayawardena TM, Schmeckpeper J, et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2011; 50: 280-9
|
|
|
|
|
|
36）Uosaki H, Yamashita JK. Chemicals Regulating Cardiomyocyte Differentiation. In: Craig Atwood, editor. Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis. Croatia: InTech; 2011. p.471-86
|
|
|
|
|
|
37）Yan P, Nagasawa A, Uosaki H, et al. Cyclo-sporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. Biochem Biophys Res Commun. 2009; 379: 115-20
|
|
|
|
|
|
38）Bersell K, Arab S, Haring B, et al. Neuregulin1/ErbB4 signaling induces cardiomyocyte prolife-ration and repair of heart injury. Cell. 2009; 138: 257-70
|
|
|
|
|
|
39）Kikuchi K, Holdway JE, Werdich AA, et al. Primary contribution to zebrafish heart regene-ration by gata4(+)cardiomyocytes. Nature. 2010; 464: 601-5
|
|
|
|
|
|
40）Jopling C, Sleep E, Raya M, et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferen-tiation and proliferation. Nature. 2010; 464: 606-9
|
|
|
|
|
|
41）Porrello ER, Mahmoud AI, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011; 331: 1078-80
|
|
|
|
|
|
42）Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010; 463: 1035-42
|
|
|
|
|
|
43）Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010; 142: 375-86
|
|
|
|
|
|
44）Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012; 485: 593-8
|
|
|
|
|
|
45）Song K, Nam YJ, Luo X, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012; 485: 599-604
|
|
|
|
|
|
46）Jayawardena TM, Egemnazarov B, Finch EA, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012; 110: 1465-73
|
|
|
|
|
|
47）Kobayashi T, Yamaguchi T, Hamanaka S, et al. Generation of rat pancreas in mouse by inter-specific blastocyst injection of pluripotent stem cells. Cell. 2010; 142: 787-99
|
|
|
|
|